About Glen Tullman
Glen Tullman is an entrepreneur, an angel investor and a board member based out of Chicago, United States. They did their education from Bucknell University in 1981. Their journey in the startup ecosystem started in 2011 through 7wire Ventures. Glen Tullman has founded 2 companies. They are currently acting as the founder of 7wire Ventures. As an angel investor, Glen Tullman has a portfolio of 1 company, focusing primarily on sectors like Real Estate and Construction Tech and Consumer. They invest in companies across United States. Their most notable investment is Homeward. Glen Tullman is currently serving as a board member at Transcarent, NOCD and 2 more companies.
Key Metrics
Location
Chicago, United States
Founded
Board Memberships
Investment Portfolio
Top sectors of Investment
Top locations of Investment
Glen Tullman's Investments
Glen Tullman has invested in 1 company, which was in Homeward (Series B Round) on Aug 04, 2022. Their investments are primarily in Real Estate and Construction Tech and Consumer. Their investment portfolio companies are located in United States.Here is the detail of this recent investment:
Date | Company | Round | Round Amount | Co-Investors |
|---|---|---|---|---|
Aug 04, 2022 | Series B | $50M |
Glen Tullman's Founded Companies
Glen Tullman has founded 2 companies namely 7wire Ventures and Zest Health.
Here are the details of all founded companies by Glen Tullman:
Company | Short Description | Total Funding | Founded Year | Current Stage | Location |
|---|---|---|---|---|---|
Invests in early-stage digital health companies empowering informed, connected health consumers | - | 2011 | Unfunded | Chicago | |
Virtual dermatology for psoriasis and eczema, expert care made effortless | $6M | 2013 | Series A | Chicago |
Glen Tullman's Board Memberships
Glen Tullman has 4 current board memberships including Transcarent and NOCD.Here is the list of top board memberships by Glen Tullman:
Company | Description | Total Funding | Current Stage | Membership Status | Appointment Date | Cessation Date |
|---|---|---|---|---|---|---|
Provider of employee health benefits solutions | $424M | Series D | CURRENT | Apr 22, 2025 | - | |
Mobile app for treating obsessive-compulsive disorder | $85M | Series C | CURRENT | Feb 06, 2018 | - |
FAQs about Glen Tullman
Recently updated other profiles
